Analysis of insulin-like growth factors and insulin-like growth factor I receptor expression in renal cell carcinoma

American Journal of Clinical Pathology

Volumn 122, Issue 6, 2004, Pages 931-937

  Schips, Luigi ^a   Zigeuner, Richard ^a   Ratschek, Manfred ^a   Rehak, Peter ^a   Rüschoff, Josef ^b   Langner, Cord ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Institute of Pathology   (Germany)

Author keywords

Histologic subtype; IGF I; IGF II; IGF IR; Immunohistochemistry; Insulin like growth factor I receptor; Insulin like growth factors; Renal cell carcinoma

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CELL STIMULATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR CELL;

EID: 9644302316     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/G7PY0RE7T86HHQYV     Document Type: Article

References (39)

1. McLaughlin JK, Lipworth L. Epidemiologic aspects of renal cell cancer. Semin Oncol. 2000;27:115-123.
2. Méjean A, Oudard S, Thiounn N. Prognostic factors of renal cell carcinoma. J Urol. 2003;169:821-827.
3. Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic features among histological subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27:612-624.
4. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000;92:1472-1489.
5. Fürstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol. 2002;3:298-302.
6. LeRoith D, Roberts CT Jr. The insulin-like growth factor system and cancer. Cancer Lett. 2003;95:127-137.
7. Andre F, Rigot V, Thimonier J, et al. Integrins and E-cadherin cooperate with IGF-I to induce migration of epithelial colonic cells. Int J Cancer. 1999;83:497-505.
8. Mauro L, Salerno M, Morelli C, et al. Role of the IGF-I receptor in the regulation of cell-cell adhesion: implications in cancer development and progression. J Cell Physiol. 2003;194:108-116.
9. Reinmuth N, Fan F, Liu W, et al. Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest. 2002;82:1377-1389.
10. Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet. 1998;351:1393-1396.
11. Chan JM, Stampfer MJ, Giovannucci E, et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science. 1998;279:563-566.
12. Yu H, Spitz MR, Mistry J, et al. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control study. J Natl Cancer Inst. 1999;91:151456.
13. Ma J, Pollak MN, Giovannucci E, et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst. 1999;91:620-625.
14. Werner H, Karnieli E, Rauscher FJ, et al. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci U S A. 1996;93:8318-8323.
15. Ouban A, Muraca P, Yeatman T, et al. Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas. Hum Pathol. 2003;34:803-808.
16. Peters G, Gongoll S, Langner C, et al. 1GF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal cancer. Virchows Arch. 2003;443:139-145.
17. Kellerer M, von Eye Corleta H, Mühlhofer A, et al. Insulin- and insulin-like growth factor-I receptor tyrosine-kinase activities in human renal cell carcinoma. Int J Cancer. 1995;62:501-507.
18. Parker AS, Cheville JC, Janney CA, et al. High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas. Hum Pathol. 2002;33:801-805.
19. Parker AS, Cheville JC, Lohse C, et al. Expression of insulin-like growth factor-I receptor and survival in patients with clear cell renal cell carcinoma. J Urol. 2003;170:420-424.
20. Ramp U, Jaquet K, Reinecke P, et al. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type. J Urol. 1997;157:2345-2350.
21. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumors, 6th ed. New York, NY: Wiley-Liss; 2002.
22. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:655-663.
23. Eble JN, Togashi K, Pisani P. Renal cell carcinoma. In: Eble JN, Sauter G, Epstein JI, et al, eds. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; 2004:93-109. World Health Organization Classification of Tumours.
24. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844-847.
25. Zumkeller W, Schofield PN. The role of insulin-like growth factors and IGF-binding proteins in the physiological and pathological processes of the kidney. Virchows Arch B Cell Pathol Incl Mol Pathol. 1992;62:207-220.
26. Hakam A, Yeatman TJ, Lu L, et al. Expression of insulin-like growth factor-1 receptor in human colorectal cancer. Hum Pathol. 1999;30:1128-1133.
27. Schnarr B, Strunz K, Ohsam J, et al. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer. Int J Cancer. 2000;89:506-513.
28. Vella V, Sciacca L, Pandini G, et al. The IGF system in thyroid cancer: new concepts. Mol Pathol. 2001;54:121-124.
29. Eppler E, Zapf J, Bailer N, et al. IGF-I in human breast cancer: low differentiation stage is associated with decreased IGF-I content. Eur J Endocrinol. 2002;146:813-821.
30. Weber MM, Fottner C, Liu SB et al. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas. Cancer. 2002;95:2086-2095.
31. Cardillo MR, Monti S, Di Selverio F, et al. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer. Anticancer Res. 2003;23:3825-3835.
32. Pekonen F, Partanen S, Rutanen EM. Binding of epidermal growth factor and insulin-like growth factor-I in renal cell carcinoma and adjacent normal kidney tissue. Int J Cancer. 1989;43:1029-1033.
33. Kondo K, Yao M, Yoshida M, et al. Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters. Genes Chromosomes Cancer. 2002;34:58-68.
34. Datta K, Nambudripad R, Pal S, et al. Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer. J Biol Chem. 2000;275:20700-20706.
35. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10:537-544.
36. Delahunt B, Eble JN, McCredie MRE, et al. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol. 2001;32:590-595.
37. Bennington JL, Strathearn M, Spencer EM, et al. Implications of insulin-like growth factors in renal cell carcinoma. Eur Urol. 1990;18(suppl 2):13-14.
38. Holt RI, Teale JD, Jones JS, et al. Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia. Growth Horm IGF Res. 1998;8:447-454.
39. Berman J, Harland S. Hypoglycemia caused by secretion of insulin-like growth factor 2 in a primary renal cell carcinoma. Clin Oncol (R Coll Radiol). 2001;13:367-369.